Pelthos Therapeutics (PTHS) Total Liabilities (2022 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Total Liabilities of $91.5 million for Q4 2025, up 2141.39% year-over-year from $4.1 million in Q4 2024, and up 34.23% quarter-over-quarter from $68.2 million in Q3 2025.
Pelthos Therapeutics (PTHS) Total Liabilities (2022 - 2026) Analysis & Trends
Pelthos Therapeutics' Total Liabilities history runs 4 years deep, the most recent figure standing at $91.5 million for Q4 2025.
- In Q4 2025, Total Liabilities rose 2141.39% year-over-year to $91.5 million; the TTM figure through Dec 2025 stood at $91.5 million (up 2141.39% YoY), while the FY2025 annual figure was $91.5 million, up 2141.39% from the prior year.
- Total Liabilities for Q4 2025 stood at $91.5 million, up from $68.2 million in the prior quarter.
- The five-year high for Total Liabilities was $91.5 million in Q4 2025, with the low at $2.8 million in Q2 2024.
- The 4-year median for Total Liabilities is $4.6 million (2024), against an average of $19.6 million.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities tumbled 37.58% in 2024, then soared 2141.39% in 2025.
- Pelthos Therapeutics' Total Liabilities stood at $3.8 million in 2022, then soared by 73.89% to $6.5 million in 2023, then sank by 37.58% to $4.1 million in 2024, then jumped by 2141.39% to $91.5 million in 2025.
- Business Quant data shows PTHS's Total Liabilities at $91.5 million in Q4 2025, $68.2 million in Q3 2025, and $7.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 10.03 Bn |
| 10 | Pelthos Therapeutics | 95.35 Mn | 70.79 Mn | 21.23 Mn | 138.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 138.86 Mn |
| Dec 31, 2025 | 91.52 Mn |
| Sep 30, 2025 | 68.18 Mn |
| Jun 30, 2025 | 7.32 Mn |
| Mar 31, 2025 | 5.11 Mn |
| Dec 31, 2024 | 4.08 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Dec 31, 2023 | 6.54 Mn |
| Dec 31, 2022 | 3.76 Mn |